Published in ACS Chem Neurosci on January 27, 2010
Lipid vesicles trigger α-synuclein aggregation by stimulating primary nucleation. Nat Chem Biol (2015) 1.22
Acceleration of α-synuclein aggregation by exosomes. J Biol Chem (2014) 1.04
In silico theoretical molecular modeling for Alzheimer's disease: the nicotine-curcumin paradigm in neuroprotection and neurotherapy. Int J Mol Sci (2011) 1.01
On the lag phase in amyloid fibril formation. Phys Chem Chem Phys (2015) 0.98
The effect of nanoparticles on amyloid aggregation depends on the protein stability and intrinsic aggregation rate. Langmuir (2012) 0.88
Nanoparticles in relation to peptide and protein aggregation. Int J Nanomedicine (2014) 0.88
Charge dependent retardation of amyloid β aggregation by hydrophilic proteins. ACS Chem Neurosci (2014) 0.85
Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation. Nat Commun (2016) 0.84
Influence of the physiochemical properties of superparamagnetic iron oxide nanoparticles on amyloid β protein fibrillation in solution. ACS Chem Neurosci (2013) 0.82
Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents. ACS Chem Neurosci (2013) 0.82
Food chain transport of nanoparticles affects behaviour and fat metabolism in fish. PLoS One (2012) 0.81
Effects of macromolecular crowding on amyloid beta (16-22) aggregation using coarse-grained simulations. J Phys Chem B (2014) 0.81
Protein corona: Opportunities and challenges. Int J Biochem Cell Biol (2016) 0.81
Potential applications of magnetic particles to detect and treat Alzheimer's disease. Nanoscale Res Lett (2014) 0.81
Effects of polyamino acids and polyelectrolytes on amyloid β fibril formation. Langmuir (2014) 0.79
Retardation of Abeta fibril formation by phospholipid vesicles depends on membrane phase behavior. Biophys J (2010) 0.79
Quantitative analysis of intrinsic and extrinsic factors in the aggregation mechanism of Alzheimer-associated Aβ-peptide. Sci Rep (2016) 0.78
Fluorescent filter-trap assay for amyloid fibril formation kinetics in complex solutions. ACS Chem Neurosci (2015) 0.78
Effects of hydrophobic macromolecular crowders on amyloid β (16-22) aggregation. Biophys J (2015) 0.77
How Do the Size, Charge and Shape of Nanoparticles Affect Amyloid β Aggregation on Brain Lipid Bilayer? Sci Rep (2016) 0.76
Contrasting effects of nanoparticle-protein attraction on amyloid aggregation. RSC Adv (2015) 0.75
Influence of gold nanoparticle surface chemistry and diameter upon Alzheimer's disease amyloid-β protein aggregation. J Biol Eng (2017) 0.75
Facet-Dependent Interactions of Islet Amyloid Polypeptide with Gold Nanoparticles: Implications for Fibril Formation and Peptide-Induced Lipid Membrane Disruption. Chem Mater (2017) 0.75
Antibody-conjugated, dual-modal, near-infrared fluorescent iron oxide nanoparticles for antiamyloidgenic activity and specific detection of amyloid-β fibrils. Int J Nanomedicine (2013) 0.75
Critical Influence of Cosolutes and Surfaces on the Assembly of Serpin-Derived Amyloid Fibrils. Biophys J (2017) 0.75
Functionalisation of Polyvinylpyrrolidone on Gold Nanoparticles Enhances Its Anti-Amyloidogenic Propensity towards Hen Egg White Lysozyme. Biomedicines (2017) 0.75
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science (2002) 49.51
Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem (2006) 22.87
Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron (2004) 4.88
Analysis of protein aggregation kinetics. Methods Enzymol (1999) 3.97
Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry (2001) 3.47
Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J Biol Chem (2007) 3.42
Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci U S A (2007) 3.23
Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly. Proc Natl Acad Sci U S A (2008) 2.90
Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. Proc Natl Acad Sci U S A (1991) 2.19
Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process. ACS Chem Neurosci (2009) 1.75
A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptide. FEBS J (2009) 1.71
Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles. J Am Chem Soc (2008) 1.60
Inhibition of toxicity in the beta-amyloid peptide fragment beta -(25-35) using N-methylated derivatives: a general strategy to prevent amyloid formation. J Biol Chem (2000) 1.44
Aggregation and catabolism of disease-associated intra-Abeta mutations: reduced proteolysis of AbetaA21G by neprilysin. Neurobiol Dis (2008) 1.23
SDS-induced fibrillation of alpha-synuclein: an alternative fibrillation pathway. J Mol Biol (2010) 1.22
Conformational changes of the amyloid beta-peptide (1-40) adsorbed on solid surfaces. Macromol Biosci (2005) 1.06
TiO2 nanoparticles promote beta-amyloid fibrillation in vitro. Biochem Biophys Res Commun (2008) 1.03
Inhibition of IAPP and IAPP(20-29) fibrillation by polymeric nanoparticles. Langmuir (2010) 1.03
Fullerene inhibits beta-amyloid peptide aggregation. Biochem Biophys Res Commun (2003) 1.01
Influence of fluorinated and hydrogenated nanoparticles on the structure and fibrillogenesis of amyloid beta-peptide. Biophys Chem (2008) 0.98
Requirements for generating sigmoidal time-course aggregation in nucleation-dependent polymerization model. Biophys Chem (2004) 0.92
Inhibition of the formation of amyloid beta-protein fibrils using biocompatible nanogels as artificial chaperones. FEBS Lett (2006) 0.91
Influence of dendrimer's structure on its activity against amyloid fibril formation. Biochem Biophys Res Commun (2006) 0.90
Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A (2007) 7.50
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A (2008) 5.76
Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol (2012) 3.48
Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed Engl (2007) 3.41
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol (2013) 3.39
Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci U S A (2007) 3.23
Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc (2011) 3.19
What the cell "sees" in bionanoscience. J Am Chem Soc (2010) 3.07
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism. Proc Natl Acad Sci U S A (2013) 2.89
Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano (2012) 2.59
Protein-nanoparticle interactions: opportunities and challenges. Chem Rev (2011) 2.34
Methods for the detection and analysis of protein-protein interactions. Proteomics (2007) 2.29
The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv Colloid Interface Sci (2007) 2.22
The evolution of the protein corona around nanoparticles: a test study. ACS Nano (2011) 2.05
Detecting cryptic epitopes created by nanoparticles. Sci STKE (2006) 2.02
Protein-nanoparticle interactions: What does the cell see? Nat Nanotechnol (2009) 2.00
Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population. Nat Nanotechnol (2011) 1.90
Amyloid β-protein aggregation produces highly reproducible kinetic data and occurs by a two-phase process. ACS Chem Neurosci (2009) 1.75
A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptide. FEBS J (2009) 1.71
Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles. J Am Chem Soc (2008) 1.60
Structure and functional properties of the Bacillus subtilis transcriptional repressor Rex. Mol Microbiol (2008) 1.49
Complete high-density lipoproteins in nanoparticle corona. FEBS J (2009) 1.47
Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. J Am Chem Soc (2013) 1.44
Quantification of nanoparticle uptake by cells using an unbiased sampling method and electron microscopy. Nanomedicine (Lond) (2011) 1.43
Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery". J Control Release (2012) 1.41
Exposure assessment: recommendations for nanotechnology-based pesticides. Int J Occup Environ Health (2011) 1.39
Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices. Nanotoxicology (2010) 1.38
Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity. Nano Lett (2007) 1.37
Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One (2011) 1.36
Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. ACS Nano (2012) 1.35
Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: toward models of uptake kinetics. Nanomedicine (2011) 1.35
Modeling the time evolution of the nanoparticle-protein corona in a body fluid. PLoS One (2010) 1.34
Measurement of Ca2+-binding constants of proteins and presentation of the CaLigator software. Anal Biochem (2002) 1.34
Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials (2010) 1.34
Calbindin D28k exhibits properties characteristic of a Ca2+ sensor. J Biol Chem (2002) 1.29
Emerging methods and tools for environmental risk assessment, decision-making, and policy for nanomaterials: summary of NATO Advanced Research Workshop. J Nanopart Res (2008) 1.28
Residue-specific pKa determination of lysine and arginine side chains by indirect 15N and 13C NMR spectroscopy: application to apo calmodulin. J Am Chem Soc (2007) 1.25
Reproducible comet assay of amorphous silica nanoparticles detects no genotoxicity. Nano Lett (2008) 1.25
Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines. Small (2011) 1.25
The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes. Nanomedicine (2013) 1.25
Time and space resolved uptake study of silica nanoparticles by human cells. Mol Biosyst (2010) 1.25
140 mouse brain proteins identified by Ca2+-calmodulin affinity chromatography and tandem mass spectrometry. J Proteome Res (2006) 1.21
Fate and effects of CeO2 nanoparticles in aquatic ecotoxicity tests. Environ Sci Technol (2009) 1.20
Nanotoxicology: nanoparticles reconstruct lipids. Nat Nanotechnol (2009) 1.19
Nanopesticides: guiding principles for regulatory evaluation of environmental risks. J Agric Food Chem (2014) 1.12
Therapeutic nanoparticles in clinics and under clinical evaluation. Nanomedicine (Lond) (2013) 1.11
Surface-induced changes in protein adsorption and implications for cellular phenotypic responses to surface interaction. Biomaterials (2006) 1.10
Binding of calcium ions and SNAP-25 to the hexa EF-hand protein secretagogin. Biochem J (2007) 1.09
Nanobiotechnology: nanoparticle coronas take shape. Nat Nanotechnol (2011) 1.09
Protein reconstitution and three-dimensional domain swapping: benefits and constraints of covalency. Protein Sci (2007) 1.08
Classification framework for graphene-based materials. Angew Chem Int Ed Engl (2014) 1.06
Surface effects on aggregation kinetics of amyloidogenic peptides. J Am Chem Soc (2014) 1.06
Isolation and detection of human IgA using a streptococcal IgA-binding peptide. J Immunol (2002) 1.06
Calmodulin binding to the polybasic C-termini of STIM proteins involved in store-operated calcium entry. Biochemistry (2008) 1.06
Myo-inositol monophosphatase is an activated target of calbindin D28k. J Biol Chem (2002) 1.05
Salting the charged surface: pH and salt dependence of protein G B1 stability. Biophys J (2006) 1.05
HAMLET kills tumor cells by an apoptosis-like mechanism--cellular, molecular, and therapeutic aspects. Adv Cancer Res (2003) 1.05
Quantification of the concentration of Aβ42 propagons during the lag phase by an amyloid chain reaction assay. J Am Chem Soc (2013) 1.03
Novel method to prepare morphologically rich polymeric surfaces for biomedical applications via phase separation and arrest of microgel particles. J Phys Chem B (2006) 1.03
Phase equilibria and glass transition in colloidal systems with short-ranged attractive interactions: application to protein crystallization. Phys Rev E Stat Nonlin Soft Matter Phys (2002) 1.03
In vitro developmental toxicity test detects inhibition of stem cell differentiation by silica nanoparticles. Toxicol Appl Pharmacol (2009) 1.02
Correlation signature of the macroscopic states of the gene regulatory network in cancer. Proc Natl Acad Sci U S A (2009) 1.01
Nanomaterial categorization for assessing risk potential to facilitate regulatory decision-making. ACS Nano (2015) 1.01
High affinity antibodies to Plasmodium falciparum merozoite antigens are associated with protection from malaria. PLoS One (2012) 1.01
Interaction of soft condensed materials with living cells: phenotype/transcriptome correlations for the hydrophobic effect. Proc Natl Acad Sci U S A (2003) 1.00
Protein fibrillation and nanoparticle interactions: opportunities and challenges. Nanoscale (2013) 1.00
pK(a) values for side-chain carboxyl groups of a PGB1 variant explain salt and pH-dependent stability. Biophys J (2006) 1.00
Surface coatings shape the protein corona of SPIONs with relevance to their application in vivo. Langmuir (2012) 0.99
Membrane interaction of α-synuclein in different aggregation states. J Parkinsons Dis (2011) 0.98